Generational Equity, a leading mergers and acquisitions advisor for privately-held, middle-market businesses, is pleased to announce the recapitalization of its client, Electromedical Products International, Inc. (EPI), headquartered in Mineral Wells, Texas, by Tilley Capital, LLC, headquartered in Charlotte, North Carolina. The transaction closed on June 30, 2016.

EPI is a medical device company engaged in the manufacturing and marketing of Alpha-Stim, a handheld, non-invasive device used to treat anxiety, insomnia, depression, and pain. EPI's patented technology is sold worldwide, with product literature in 19 different languages. The company sells through independent representatives and distributors. EPI also markets its products to the US Department of Defense and Veterans Affairs.

Managing Director Michael Goss and Vice President Bryan Gooden led the Generational Equity deal team that advised EPI on the transaction. "Based on Tillery Capital's past experience in driving company growth organically and through complementary add-on acquisitions, EPI has a very bright and exciting future in the years to come," stated Bryan Gooden.

Tillery Capital is an operationally oriented, family-office structured private investment firm that invests in and builds lower middle-market companies in partnership with their management teams. Its team is comprised of "hands-on," consultative investors that focus on companies where the owners or management team are still hungry to grow their business, but have concluded they want a value-added equity partner to help them get it done. Tillery Capital team members include Chris Weidenhammer, CFA, Richard Fetter, PhD, and James Buck, PE. To learn more, visit, www.tillerycapital.com.

About Generational Equity

Generational Equity, headquartered in Dallas, helps business owners release the wealth of their business by providing merger, acquisition and strategic growth advisory services. Our four-step approach features M&A education, financial analysis and reporting, sales documentation and deal-making. Our team was recently recognized by M&A Advisor as Valuation Firm of the Year.